SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-046887
Filing Date
2017-09-06
Accepted
2017-09-06 19:26:55
Documents
1
Period of Report
2017-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 v474755_form3.html 3  
1 FORM 3 v474755_form3.xml 3 2495
  Complete submission text file 0001144204-17-046887.txt   3850
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
Reines Scott (Reporting) CIK: 0001716401 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 171072485